COVID-19 AND PNEUMOCYSTIS PNEUMONIA IN A PATIENT WITH HIV INFECTION

DOI: https://doi.org/10.29296/25877305-2021-11-07
Download full text PDF
Issue: 
11
Year: 
2021

Associate Professor L. Povalyaeva(1, 2), Candidate of Medical Sciences; A. Sukhanova(1, 2); E.
Yakovleva(1); Professor B. Borodulin(1), MD; O. Ushmodina(2); L. Peshkova(2) (1)Samara State Medical
University of the Ministry of Health of Russia (2)Samara City Hospital Fourth

Changes in lung tissue like ground-glass opacities are typical for many lung diseases, but in modern conditions, the main diagnosis in identifying increasing respiratory symptoms with a change on CT is the diagnosis «New coronavirus infection COVID-19, Bilateral polysegmental viral pneumonia”. The existing danger of «missing» another diagnosis is very high. Opportunities for high-quality differential diagnostics are significantly reduced. The aim is to show a clinical example of the comorbidity of a viral infection in a patient with HIV infection with severe immunodeficiency. Materials and methods. The clinical example from the practice of the COVID-19 is presented. Results. In a patient with a typical course of COVID-19, negative dynamics appeared during long-term treatment on day 37. Examination revealed an increase in symptoms and lung damage up to 85%. Further examination revealed HIV infection for the first time, confirmed by immunoblot at the stage of severe immunodeficiency (CD4 20 cells/μl). Pneumocystis pneumonia has been diagnosed. The patient died, although the treatment was carried out in full. Conclusion. During the COVID-19 pandemic, there is the possibility of a comorbid COVID-19 disease and other diseases that also have a ground-glass opacities.
Keywords: 
infectious diseases
COVID-19
ground-glass opacities
Pneumocystis pneumonia
immunodeficiency
HIV infection

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061–9. DOI: 10.1001/jama.2020.1585
  2. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
  3. Rigamonti E., Salera D., Gheorghiu A.C. et al. The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection. Swiss Med Wkly. 2020; 150: w20312. DOI: 10.4414/smw.2020.20312
  4. Zieda A., Sbardella S., Patel M. et al. Diagnostic Bias in the COVID-19 Pandemic: A Series of Short Cases. Eur J Case Rep Intern Med. 2021; 8 (5): 002575. DOI: 10.12890/2021002575
  5. Korb T.A., Gavrilov P.V., Chernina V.Ju. i dr. Spetsifichnost' komp'juternoj tomografii organov grudnoj kletki pri pnevmonii, assotsiirovannoj s COVID-19: retrospektivnoe issledovanie. Al'manah klinicheskoj meditsiny. 2021; 49 (1): 1–10 [Korb T.A., Gavrilov P.V., Chernina V.Yu. et al. Specificity of chest computed tomography in COVID-19-associated pneumonia: a retrospective study. Almanac of Clinical Medicine. 2021; 49 (1): 1-10 (in Russ.)]. DOI: 10.18786/2072-0505-2021-49-001
  6. Borodulina E.A., Jakovleva E.V., Povaljaeva L.V. i dr. Sravnitel'noe issledovanie gepsidina syvorotki krovi patsientov s porazheniem legkih pri COVID-19 i pnevmotsistnoj pnevmonii. Klinicheskaja laboratornaja diagnostika. 2021; 66 (11): 645–9 [Borodulina E.A., Yakovleva E.V., Povalyaeva L.V. et al. Comparative study of the serum hepcidin level of patients with pneumonia in COVID-19 and Pneumocystis pneumonia. Klinicheskaya laboratornaya diagnostika. 2021; 66 (11): 645–9 (in Russ.)]. DOI: 10.51620/0869-2084-2021-66-11-645-649
  7. Kudlaj D.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika COVID-19. Sposoby i problemy obnaruzhenija virusa SARS-COV-2 v uslovijah pandemii. Vrach. 2020; 31 (8): 5–10 [Kudlay D., Shirobokov YA., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-COV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.)]. DOI: 10.29296/25877305-2020-08-01
  8. Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20 (4): 425–34. DOI: 10.1016/S1473-3099(20)30086-4
  9. Zhao W., Zhong Z., Xie X. et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am J Roentgenol. 2020; 214 (5): 1072–7. DOI: 10.2214/AJR.20.22976
  10. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210 [Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.)]. DOI: 10.33029/0206-4952-2021-42-3-198-210
  11. Borodulina E.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika i farmakoterapija virus-assotsiirovannyh porazhenij legkih. Klinicheskaja farmakologija i terapija. 2020; 29 (3): 61–6 [Borodulina E., Shirobokov Y., Gladunova E. et al. Virus-associated lung disease. Clinical pharmacology and therapy. 2020; 29 (3): 61–6 (in Russ.)]. DOI: 10.32756/0869-5490-2020-3-61-66
  12. Choy C.Y., Wong C.S. It’s not all about COVID-19: pneumocystis pneumonia in the era of a respiratory outbreak. J Int AIDS Soc. 2020; 23 (6): e25533. DOI: 10.1002/jia2.25533
  13. Kelly S., Waters L., Cevik M. et al. Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19. Clin Med (Lond). 2020; 20 (6): 590–2. DOI: 10.7861/clinmed.2020-0565
  14. Sajjad M.M., Yousaf S., Ullah S. A Diagnostic Challenge in COVID-19 Pandemic: PCP or COVID-19. J Coll Physicians Surg Pak. 2020; 30 (10): 144. DOI: 10.29271/jcpsp.2020.supp2.144
  15. Bhat P., Noval M., Doub J.B. et al. Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient. Int J Infect Dis. 2020; 99: 119–21. DOI: 10.1016/j.ijid.2020.07.061
  16. Aver'janov A.V., Sotnikova A.G., Lesnjak V.N. Pnevmotsistnaja pnevmonija, mimikrirujuschaja pod COVID-19. Klinicheskaja praktika. 2020; 11 (2): 87–92 [Averyanov A.V., Sotnikova A.G., Lesnyak V.N. Pneumocystis Pneumonia Mimicking COVID-19. Journal of Clinical Practice. 2020; 11 (2): 87–92 (in Russ.)]. DOI: 10.17816/clinpract34995 Broadhurst A.G.B., Lalla U., Taljaard J.J. et al. The diagnostic challenge of pneumocystis pneumonia and COVID-19 co-infection in HIV. Respirol Case Rep. 2021; 9 (4): e00725. DOI: 10.1002/rcr2.725